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Structural implications of Dpy30
oligomerization for MLL/SET1 COMPASS H3K4
trimethylation
Dear Editor,
The methylation modiﬁcations of histone 3 lysine 4 (H3K4)
have essential effects on biological processes including
gene expression and transcription, cell cycle progression,
and DNA repair. From yeast to mammals, the SET1 and
MLL-like (mixed-lineage leukemia) multi-subunit protein
complexes, known as SET1 or MLL COMPASS (Schneider
et al., 2005), are responsible for H3K4 methylation. In
addition to the catalytic SET domain, the SET1 and MLL
COMPASS complexes also contain a number of conserved
subunits including WDR5 (Cps30), RbBP5 (Cps50), Ash2L
(Cps60 or Bre2), and Dpy30 (Cps25 or Sdc1). Dpy30 is an
important subunit of MLL/SET1 complexes, where it plays an
essential role in both catalyzing H3K4 trimethylation and
maintaining the state of trimethylated H3K4. Many regulatory
gene loci in undifferentiated embryonic stem cells (ESCs)
exhibit both H3K4 and H3K27 methylation modiﬁcations, the
so-called bivalent marks, which poise the genes for
expression (Azuara et al., 2006; Bernstein et al., 2006; Pan
et al., 2007). Dpy30 is the subunit that regulates chromo-
somal H3K4 trimethylation (H3K4me3) throughout the
mammalian genome by MLL complexes; deletion of Dpy30
alters the differentiation process of ESCs (Jiang et al., 2011).
Dpy30 directly interacts with Ash2L in human (Bre2 in
yeast) COMPASS through its Dpy30-binding motif (DBM)
(South et al., 2010). Recent in vitro and in vivo studies
indicate that both Dpy30 and Ash2L are important for the
H3K4 trimethylation activity of SET1/MLL complexes (Dou
et al., 2006; Patel et al., 2011). Although the structures of the
human Dpy30 C-terminal domain (Dpy30C) and SPRY
domain of Ash2L containing the DBM motif were solved
(Wang et al., 2009b), the binding mode and stoichiometry of
Dpy30 and Ash2L within COMPASS remain uncertain, partly
because the complex structure is lacking.
The DBM motif sequences of human Ash2L and yeast
Bre2 share 25.9% identity and 46.2% similarity. Also, human
Dpy30 and yeast Sdc1 have a conserved Dpy30 domain of
about 41 amino acids with 37% identity and 74% similarity.
To investigate the interaction between Dpy30 and Ash2L/
Bre2, we synthesized their DBM motifs (Ash2LDBM and
Bre2DBM), measured their binding afﬁnity with Dpy30FL as
well as Dpy30C using isothermal titration calorimetry (ITC).
We found that the Kd values are very similar (Fig. 1A–C),
indicating that the two peptides have a similar interacting
afﬁnity with Dpy30. The ITC results also conﬁrm the previous
report (South et al., 2010) that Dpy30C is the region of the
Dpy30 protein that binds the DBM motif.
The attempts to crystallize the Dpy30 complexed with
Ash2LDBM peptide were failed. However, the complex of
Dpy30C and Bre2DBM was crystallized successfully and the
structure (Dpy30C-Bre2DBM) was solved to 2.15 Å resolution
(Table S1). Considering the sequence similarity of the two
peptides, we believe that the structural model of Dpy30
complexed with the Bre2DBM should represent the interac-
tional pattern between Dpy30 and Ash2LDBM. The crystal
structure of Dpy30C-Bre2DBM contains two dimers of
Dpy30C (chain A and B: AB dimer; chain C and D: CD dimer)
and only one copy of Bre2DBM (chain E) in an asymmetrical
unit (Fig. 1D). The overall structure of the complex ﬁts the
electronic density well except the DBM peptide. It is difﬁcult
to reﬁne the Bre2DBM because there is always some dis-
continuous residual density around the DBM peptide in the
electronic density difference map for the ﬁnal model. After
multiple reﬁning trials, we determined that the residual den-
sity could be ﬁtted by a similar helix with a reversed orien-
tation. Finally, two separated structures, with the orientation
of the helix different from each other, were reﬁned and
showed similar qualities with Rwork/Rfree of 0.18/0.21 and
0.18/0.22 (Fig. S1A and S1B), respectively. It is likely that the
structure represents a mixed model, which was led by the
fact that some DBM helices were bound in one orientation
and the rest were in a reversed orientation in the complex
crystal (Fig. S1C). In the two types of structures, the DBM
peptide interacts with Dpy30C in the same mode and posi-
tion, although in opposite orientation. According to these
results, we used the complex model with the higher quality
for the structural comparison and discussion.
The Bre2DBM peptide interacts simultaneously with two
Dpy30C dimers, albeit with different afﬁnities. The CD dimer
plays a dominant role in Bre2DBM binding with a buried area
of about 836.2 Å2, while the AB dimer assists in the
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interaction, forming a binding area of about 292.5 Å2 with
Bre2. The interactions between Dpy30C and Bre2DBM are
mainly hydrophobic without speciﬁc hydrogen-bond or salt-
bond interactions. Ten hydrophobic residues from chains C
and D of the Dpy30C dimer are distributed symmetrically on
the inner surface in a semi-circular shape, forming a hydro-
phobic groove (Fig. 1D). Simultaneously, the Bre2DBM helix
also shows an amphiphilic characteristic. Centering on
Trp492, its hydrophobic residues arranged symmetrically,
facing toward the two Dpy30C monomers. This binding
pattern, together with the symmetric properties of both the
Bre2DBM peptide sequence and the residues in the hydro-
phobic groove of Dpy30C, might be the reason that the
Bre2DBM peptide can bind to the Dpy30C dimer in reversed
orientations without any preference. We also solved the
Dpy30 full-length (Dpy30FL) structure at a resolution of
2.13 Å (Table S1). It contains two Dyp30 molecules in an
asymmetric unit. Although we used the Dpy30FL sample for
crystallization, only the C-terminal 55 residues (amino acids
45–99) were well deﬁned in the structure. The C-terminal
domains of two Dpy30 monomers form a semi-circle hydro-
phobic groove, accommodating a helix with poorer electron
density. We can only model a fragment of poly-alanine here
without visible side chains based on the electron density
map. We deduced that this fragment could be the Dpy30
N-terminal domain because no other peptide was mixed with
the protein during puriﬁcation and crystallization. It seems
that the N-terminal domain of Dpy30 forms an N-helix that
connects to the C-terminal domain through a ﬂexible loop
that is also missing in the structure (Fig. 1E). In the Dpy30FL
dimer, two C-terminal domains fold as a four-helix bundle
and are packed tightly, while the N-helix swings randomly in
solution.
The structural characteristics of the C-terminal domain in
the Dpy30FL structure are the same as those in the Dpy30-
Bre2DBM complex and the previously reported structure
(Wang et al., 2009b). One N-terminal helix was bound in the
hydrophobic groove of the neighboring Dpy30C dimer
(Fig. 1F). Curiously, both the SPR and ITC experimental
results indicated that the Dpy30C domain had no interaction
with the Dpy30 N-helix in solution. It is possible that the
N-helix residues artiﬁcially in the hydrophobic groove of the
Dpy30C dimer because of molecular packing in the crystal.
However, it is noteworthy that the binding site is exactly the
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Figure 1. ITC analyses and structural representations of Dpy30C complexed with Bre2DBM and Dpy30FL. (A–C) Isothermal
titration calorimetry evaluation of the interaction between Dpy30FL and Ash2LDBM peptide (panel A), Dpy30C and Bre2DBM peptide
(panel B), and Dpy30C and the Ash2L peptide (panel C). (D) Overall structure of the Dpy30C in complex with Bre2DBM (Dpy30C-
Bre2DBM). The left panel shows the location of Bre2DBM. The right panel shows a cartoon-stick model of the symmetric and hydrophobic
interactions between the Bre2DBM peptide and Dpy30C. Chains A, B, C, D, and E are yellow, purple, green, magenta, and cyan,
respectively. (E) Monomer structure of Dpy30FL. The C-domain and N-helix are labeled. The part between the C-terminal domain and
N-terminal helix, which is not traced in the present structure, is shown as a dotted line. (F) Tetramer model of Dpy30FL. Four
neighboring Dpy30FL dimers are represented in light purple, cyan, green, and yellow. The N-terminal helix is accommodated by the
neighboring Dpy30C domain. Two adjacent dimers could form a tetramer. The region inside the wheat box is a model for one Dpy30C
tetramer binding two peptides. (G) Superimposed complex of the Dpy30C dimer with Bre2 peptide onto the Dpy30FL dimer binding the
N-terminal helix. The Dpy30FL dimer with N-terminal helix is green, and the Dpy30C dimer binding the Bre2 peptide is red.
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same as that observed for the Dpy30C dimer (CD) inter-
acting with the Bre2DBM peptide. Superimposition of the
Dpy30FL model and the model of the Dpy30C dimer (CD)
binding the Bre2DBM peptide (Fig. 1G) showed that, not only
the Dpy30-C dimers themselves matched very well, but also
the bound N-helix and the Bre2 peptide, with a root-mean-
square deviation of 0.6 Å. This result suggests that the
bound N-helix occupies the binding site of the target protein
of Dpy30FL in crystal. Based on the two structures above,
we presented a structural model of Dpy30C in complex with
its target helix in a 2:1 ratio, as shown in Fig. 1G. This could
be the basic unit for Dpy30 binding to Ash2L or Bre2.
The molecular packing pattern of the Dpy30FL crystal
indicates that Dpy30 oligomerizes with weak stability. The
Dpy30FL crystals belong to space group P41212. Molecules
are packed along the 41 screw axis to form a helical polymer
that has a width of ∼45 Å (Fig. S2A). The basic structure of
the helical polymer is a Dpy30 dimer, each turn of the helical
polymer includes four dimers, and any two neighboring
dimers are 1/4 units apart along the spiral axis and form a
separation angle of 90° (Fig. S2B). Two neighboring dimers
form a tetramer (Fig. 1F) that is stabilized by weak hydro-
phobic interactions. The buried area of two adjacent dimers
is 909.8 Å2, and the complexation signiﬁcance score (CSS)
value is 0.841 calculated using PISA software (http://www.
ebi.ac.uk/msd-srv/prot_int/pistart.html). Considering the
intermolecular interaction area of 1159.3 Å2 and a CSS value
of 0.867 within the dimer, the intra- and inter-dimer interac-
tion forces are approximately identical. In the Dpy30FL
structure, a Dpy30C dimer binds with one target peptide;
thus, the packing pattern presents a hexamer model of
Dpy30 interacting with target helices at a ratio of 4:2.
In the Dpy30-Bre2DBM complex structure, two Dpy30
dimers form a loose tetramer with a crossing angle of 60°
(Fig. 1D). The interface is formed between residues 47 and
71 of the neighboring chains A and D, with the buried area
occupying 549 Å2. Bre2DBM binding to Dpy30C increases
this area to 1128.7 Å2, which stabilizes the Dpy30C tetramer.
This structure represents a model of Dpy30 binding to the
target helix at the ratio of 4:1. Combined with the model of
one Dpy30 tetramer binding two peptides, these results
suggest that Dpy30 can interact with its protein partners,
such as Ash2L, at different stoichiometric values. The state
of Dpy30 binding target peptide is referred to as holo-Dpy30.
A previously reported crystal structure of Dpy30C (PDB
code 3G36) was analyzed here as a tetramer. The Dpy30C
structure contained two dimers (A and C, and B and D) with
an anti-parallel arrangement in an asymmetric unit (Fig. 2A).
The two dimers form strong interactions with an interface
area of 947.3 Å2, and the CSS value of the neighboring
dimers is 0.723. In addition, the quaternary structure
assembly of Dpy30C represents a stable tetramer or oct-
amer, as analyzed using PISA software. In the tetramer, the
contact surface was composed of residues 57–76 from
chains A and B in both dimers. Two hydrogen-bond clusters
between two dimers are important to stabilize the tetramer.
The residues T53 and R54 form as many as nine hydrogen
bonds with residues R54, D58, and Q59 from the adjacent
dimer (Fig. 2A). The Dpy30C tetramer packed too close to
accommodate one target helix (referred to as apo-Dpy30C).
Although analysis of static light scattering and analytical
ultra-centrifugation showed that in solution, bothDpy30FLand
Dpy30Care present in their dimeric forms (Fig. S3), the crystal
structures of both holo-Dpy30 and apo-Dpy30C, aswell as the
previous report (van Nuland R., 2013), all suggest the possi-
bility of Dpy30 oligomerization. Thus, we performed bio-
chemical analysis to investigate the oligomeric state of Dpy30
in solution. Cross-linkage assays using bis(sulfosuccinimidyl)
suberate (BS3) reagent indicated that the majority of both the
Dpy30 C-terminal domain and the Dpy30FL molecules form
dimers, while a small percentage of molecules forms trimers,
tetramers, and higher-order oligomers. Themonomeric bands
become weaker, while the dimeric, trimeric, and tetrameric
bands become stronger as a function of increasing concen-
trations of BS3 (Fig. 2B and 2C).
Three models of the Dpy30 tetramer with or without its
target peptide are now available. Superimposing the three
Dpy30 tetramer models showed that the dimeric structures
are almost identical (Fig. 2D). However, the relative position
between the two dimers differs substantially among the three
models. In the two structures of Dpy30 bound with target
peptides, dimer 2 makes a movement away from dimer 1,
simultaneously rotating 90° and 60°, breaking the hydrogen-
bond interactions in the apo-Dpy30 state. As an important
consequence of this movement, the space between dimers
opens wide enough to accommodate two and one target
peptide, respectively, and the conformation of the Dpy30
tetramer switches from apo-Dpy30 to holo-Dpy30 (Fig. 2E).
Our ITC results showed that the stoichiometric value N for
Dpy30 binding Bre2DBM and Ash2LDBM were all close to 0.5
(Fig. 1A–C), indicating that the ratio of Dpy30 to Ash2L or
Bre2 in solution is 2:1, which is consistent with the previous
results (Wang et al., 2009a; Chen et al., 2012) and the
Dpy30FL structure. Considering Dpy30 can form weak tet-
ramer, it might present as a tetramer and bind two Ash2L in
MLL/SET1 COMPASS. It was supported by the previous
report that the yeast COMPASS contains two copies of
Cps60/Ash2L, and at least three copies of Sdc1/Dpy30
(Schneider et al., 2005). The three-dimensional electron
microscopic model of human and yeast SET/MLL COM-
PASS displayed two subunits, Cps60/Ash2L and Cps25/
Dpy30, as three lobes of similar size forming a triangular
base structure (Takahashi et al., 2011). Since the apparent
molecular weight of the Dpy30 tetramer is about equal to the
molecular weight of an Ash2L monomer, we hypothesize that
one Dpy30 tetramer could bind one Ash2L dimer within
COMPASS. The SPRY domain containing a DBM motif of
Ash2L was structurally characterized recently (Chen et al.,
2012). The analysis of the SPRY structure indicates that
there are 10 pairs of hydrogen bonds and one disulﬁde bond
at the interface between two monomers of the SPRY
domain, and analysis using PISA software suggests that the
Crystal structures of Dpy30 and its complex with Bre2 LETTER









SPRY domain can form stable dimers in solution, supporting
our hypothesis that the Dpy30 tetramer interacts with an
Ash2L dimer within COMPASS.
Combining the structural and biochemical data, we con-
structed a Dpy30-Ash2L complex model using the structures
of the holo-Dpy30FL tetramer presented here and the SPRY
dimer reported previously (3TOJ). In this model, one copy of
the Dpy30 tetramer and two copies of the Ash2L monomer
occupy the three lobes of the triangular base of MLL/SET1
COMPASS (Fig. 2F). Two Dpy30 dimers form a weak tet-
ramer in this model; each dimer binds one Ash2L, with two
Ash2L molecules forming a weak dimer. Because of the
formation of multi-contacting surfaces in this complex model,
we believe that the hetero-hexameric form is more stable
than the Ash2L dimer or Dpy30 tetramer alone, and that it
could represent one possible state of Dpy30 interacting with
Ash2L in COMPASS.
Recently, Timmers et al. observed that Dpy30 interacted
with Ash2L with various ratios in different COMPASS com-
plexes. The ratio is 6:1 in the MLL1/2 complex (van Nuland
R., 2013), which is necessary for H3K4me3 (Wu et al., 2008;
Wang et al., 2009a); 3:1 in the MLL3/4 complex (van Nuland
R., 2013), which is critical for mono-methylation (Herz et al.,
2012); and 2:1 or 3:1 in the SETA/B complex, which is
responsible for the global levels of H3K4me3 (Lee et al.,
2007; Wu et al., 2008). This suggests that Dpy30 exists as
various oligomers of a genuine subunit in different MLL/SET
complex members. It seems that H3K4me3 requires more
copies of Dpy30 than H3K4me and H3K4me2. Based on our
structural data and cross-linking results, we suggest that
Dpy30 may regulate H3K4 methylation according to its copy
number in COMPASS. However, more cytological and bio-
chemical experiments are required to fully understand the
precise function of Dpy30 oligomerization.



















































Figure 2. Dpy30 is able to form tetramer and interact with other protein partners in its tetrameric state. (A) Cartoon and stick
model of the apo-Dpy30C tetramer (PDB code 3G36). In the right panel, the orange region (shown as cartoon helix) represents the
main interface between two neighboring dimers. The hydrogen-bond clusters (shown as stick models) ﬂank the two sides of this
region. In the left panel, a stick model shows the details of the hydrogen-bond clusters made by R54 and T53 of chain C (light pink)
connecting with R54, D58, and Q59 of chain B (yellow) (the same hydrogen-bond clusters are also formed between chains D and A).
The hydrogen bond interactions are shown as dashed lines with distances indicated. (B and C) A cross-linking assay of Dpy30C and
Dpy30FL was analyzed by 15% SDS-PAGE and are presented in panel (B) and (C), respectively. Lanes from left to right contain bis
(sulfosuccinimidyl) suberate with increasing concentrations from 0 to 1.2 mmol/L. (D) Superimposition of the three different Dpy30C
tetrameric forms. Tetramers 0, 1, and 2, representing models for Dpy30 in complex with zero, one, and two target proteins, are shown
in light pink, light purple, and green, respectively. (E) Movement between the two dimers from an apo-state to holo-state of Dpy30
tetramer. Dimer 1 is cyan and dimer 2 is yellow for all three forms of the Dpy30C tetramer. The Bre2DBM peptide is ﬁrebrick. (F) Model
of tetrameric Dpy30C (shown in ﬁrebrick) bound to the dimeric SPRY domain (PDB code: 3TOJ, shown in green). The model on the
left shows a triangular conformation with three similar-sized lobes representing one tetrameric Dpy30 and one dimeric SPRY domain.
At the center of the triangular region are four interacting β-strands from the dimeric SPRY domain. On the right, the model is turned
90° around its y-axis to better illustrate the interaction between the SPRY helices and the Dpy30 tetramer.
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